Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Kiropraktorerne Gyrst, Mehlum og Hemmsen, Kiropraktisk Klinik I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   1.9% 1.8% 1.8% 2.3% 3.6% 5.2% 14.5% 14.3%   Credit score (0-100)   72 73 72 63 52 42 15 15   Credit rating   A A A BBB BBB BBB BB BB   Credit limit (kDKK)   0.5 0.8 1.2 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,534 4,156 4,785 4,694 4,737 4,552 0.0 0.0   EBITDA   1,722 1,360 1,688 1,613 2,429 2,217 0.0 0.0   EBIT   1,634 1,205 1,520 1,450 2,269 2,067 0.0 0.0   Pre-tax profit (PTP)   1,628.2 1,197.2 1,518.3 1,444.3 2,258.2 2,066.1 0.0 0.0   Net earnings   1,628.2 1,197.2 1,518.3 1,444.3 2,258.2 2,066.1 0.0 0.0   Pre-tax profit without non-rec. items   1,628 1,197 1,518 1,444 2,258 2,066 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   763 751 622 459 300 150 0.0 0.0   Shareholders equity total   411 439 390 200 126 226 0.0 0.0   Interest-bearing liabilities   368 548 0.0 380 254 46.2 0.0 0.0   Balance sheet total (assets)   1,247 1,351 1,017 1,000 761 593 0.0 0.0   Net Debt   364 542 -35.5 375 242 39.1 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,534 4,156 4,785 4,694 4,737 4,552 0.0 0.0   Gross profit growth   2.4% -8.3% 15.1% -1.9% 0.9% -3.9% -100.0% 0.0%   Employees   6 6 7 6 5 5 0 0   Employee growth %   0.0% 0.0% 16.7% -14.3% -16.7% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,247 1,351 1,017 1,000 761 593 0 0   Balance sheet change%   77.4% 8.4% -24.8% -1.6% -23.9% -22.1% -100.0% 0.0%   Added value   1,721.6 1,360.0 1,688.2 1,612.7 2,432.2 2,216.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   586 -167 -297 -326 -319 -299 -150 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   36.0% 29.0% 31.8% 30.9% 47.9% 45.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   167.6% 92.7% 128.4% 143.8% 257.7% 305.2% 0.0% 0.0%   ROI %   287.8% 136.5% 220.9% 298.9% 472.5% 633.0% 0.0% 0.0%   ROE %   424.2% 281.8% 366.5% 489.3% 1,381.9% 1,171.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   33.0% 32.5% 38.4% 20.0% 16.6% 38.1% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   21.1% 39.8% -2.1% 23.3% 10.0% 1.8% 0.0% 0.0%   Gearing %   89.5% 124.9% 0.0% 189.4% 201.2% 20.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.2% 1.6% 0.7% 2.9% 3.5% 0.7% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   0.6 0.6 0.6 0.7 0.7 1.2 0.0 0.0   Current Ratio   0.6 0.7 0.6 0.7 0.7 1.2 0.0 0.0   Cash and cash equivalent   3.6 6.2 35.5 4.2 11.9 7.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -351.8 -312.6 -232.2 -258.8 -173.3 76.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   287 227 241 269 486 443 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   287 227 241 269 486 443 0 0   EBIT / employee   272 201 217 242 454 413 0 0   Net earnings / employee   271 200 217 241 452 413 0 0